enVVeno Medical Corporation
NVNO
$1.00
$0.033.09%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 10.96% | 5.73% | -0.63% | -2.73% | -16.73% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.03% | -2.79% | -5.59% | -7.93% | -13.87% |
| Operating Income | -6.03% | 2.79% | 5.59% | 7.93% | 13.87% |
| Income Before Tax | -11.99% | 3.55% | 7.22% | 11.68% | 18.08% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.99% | 3.55% | 7.22% | 11.68% | 18.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.99% | 3.55% | 7.22% | 11.68% | 18.08% |
| EBIT | -6.03% | 2.79% | 5.59% | 7.93% | 13.87% |
| EBITDA | -6.36% | 2.61% | 5.52% | 7.94% | 13.99% |
| EPS Basic | 15.52% | 34.21% | 41.12% | 45.65% | 46.17% |
| Normalized Basic EPS | 20.99% | 34.31% | 40.35% | 43.61% | 43.66% |
| EPS Diluted | 15.52% | 34.21% | 41.12% | 45.65% | 46.17% |
| Normalized Diluted EPS | 20.99% | 34.31% | 40.35% | 43.61% | 43.66% |
| Average Basic Shares Outstanding | 31.06% | 39.40% | 50.09% | 60.67% | 55.37% |
| Average Diluted Shares Outstanding | 31.06% | 39.40% | 50.09% | 60.67% | 55.37% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |